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Abstract. The present study was designed to evaluate the plasticity of mouse embryonic
stem cells (ESCs). Cardiac and neural differentiation of the mouse ESCs was initiated by embryoid
bodies (EBs) formation in hanging drops and in suspension. After aggregation the were transfered to
the suspension culture and then plating on to gelatin-coated tissue culture plates. Retinoic acid was
added to culture medium through out the suspension period. Cultures were observed daily withan
inverted microscope for the appearance of contracting clusters and neural filaments. At the
early,intermediate and terminal stages of differentiation, the choronotropic responses of
cardiomyocytes to cardioactive drugs were assessed,and the cardiomyocytes immunostained for
citokeratin, titin and betaIIItubulin. Our data suggest that ESCs can differentiate into functional
mature cardiomyocytes in vitro. Furthermore, ESC-cardiomyocytes may provide an ideal model for
the study of cardiomyocytic development and may be useful for cell therapy of various cardiac
diseases.
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Embryonic stem cells (ESCs) are expected to become a powerful tool for future
regenerative medicine and developmental biology due to their capacity for self-renewal and
pluripotency (12). During the last decade, embryonic stem cells (ESC) have unleashed new
avenues in the field of developmental biology and emerged as a potential tool to understand
the molecular mechanisms taking place during the process of differentiation from the
embryonic stage to adult phenotype. Developmental fate of differentiating stem cells depends
on the complex ‘cocktail’ of growth factors, signaling molecules, and extracellular matrix
(ECM) proteins constituting the developmental ‘niche’ in which the cells exist (4,5). In
general, they share the following characteristics: (1) a high capacity for self-renewal; (2) the
potential for multipotent differentiation potential; (3) the ability to be cultured ex vivo and
used for tissue engineering (reprogramming); and (4) plasticity (transdifferentiating ability)
(1,2,4,10, 11,14).These unique properties have provided added impetus to this area of research.
Among the specialized cell types that can be induced in vitro, cardiomyocytes are particularly
conspicuous, giving rise to rhythmically contracting structures containing cells highly
reminiscent of normal human heart cells (8). Myocardial infarction (MI) and congestive heart
failure are the leading causes of morbidity and mortality worldwide (3). Owing to the paucity
of donor hearts for transplantation, and existing pharmacological approaches being insufficient
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to reverse progressive heart failure, establishment of alternative methods has emerged at an
astonishing rate. Cell replacement therapy would consider transplantation of appropriate heart
cells to the infarcted area, regenerating at least part of the dysfunctional myocardium, securing
fresh heart muscle necessary to regain organ function.
Theoretically, ESC-derived cardiomyocytes are apt for the purpose of cardiac cell
therapy since they demonstrate reproducible differentiation of multiple cardiac cell types in
large numbers, prolonged survival and site-specific engraftment which are the keys to success
in tissue replacement therapy (5,12).
The aim of this study was to evaluate the plasticity of mouse embryonic stem cells in
vitro. To assess the ability of mouse embryonic stem cells were chosen different differentiation
protocols.
MATERIALS AND METHODS
We used at our experiment the mouse ES cell line CDE1 with a normal karyotype, at
10th passages, obtained from inner cell mass of a CD1/EGFP strain mouse blastocysts in our
laboratory. CDE1 cells were kept on primary embryonic mouse fibroblast feeder layer, in
Dulbecco’s modified Eagle’s medium (KO-DMEM medium) (GIBCO) supplemented with
glutamax (Gibco, 100x), 50 µg/ml streptomycin (SIGMA), 50U/ml penicillin (SIGMA),
50mM β-mercaptoethanol (ME) (SIGMA), 0.1mM non-essential amino acids (GIBCO), 1000
units/ml of leukemia inhibitory factor (ESGRO) and 20% fetal calf serum (FCS) (HyClone).
Two days before the differentiation, ES cells were passaged into gelatin (0.1%)
(SIGMA) coated petri dishes (Greiner) in the ES culture medium.
On the appointed day 0 of differentiation, we passage the cells into 10 cm
bacteriological dishes, containing 5x106 ES cells in 10 ml differentiation medium (Day 0 of
differentiation). As differentiation medium the IMDM (Gibco) medium supplemented with
0.6 m/m% penicillin, 1  m/m% streptomycin and 20v/v% FCS was employed. MTG
(monothyoglycerol) 3 μl/ml was always freshly added to the differentiation medium. For
hanging drop production 2x104 cells/ml containing cell-suspension was prepared in IMDM
differentiation medium.
From this suspension, three Petri dish covers with 70 hanging-drops (a drop of 20 µl,
contained 400 mouse ES cells) and one suspension Petri dish (3 ml cell suspension) were set
in culture for two days (Day 2). Cell aggregates were obtained after 5–6 hrs, while EBs were
morphologically completed after 2 days, by each procedure. The second step was to plate the
EBs on a geltin-coated surface for 17 days (Day2+7). Best EBs from the hanging-drops and
from the cell suspension were separately harvested and pooled EBs from each variant were
further grown on 24-well tissue culture dishes. Prior cultivation of EBs, a rounded shaped
histologic cover slip was introduced within each well in order to later perform immuno-
staining. All culture dishes so prepared, were gelatin-coated before addition of EBs.
For cardiomyocytes differentiation, 48 EBs were further plated in two 24-well tissue
culture plates within IMDM medium/MTG. Every second day the medium was changed for
17 days. For neuronal differentiation, 48 EBs were further plated in two 24-well tissue culture
plates within IMDM medium/MTG and 10-6M retinoic acid (RA). Every second day the
medium was changed for 17 days, but RA was added at the first four days.
With daily observation, the percent of beating EBs was determined up to 19 days after
plating. For evaluating the function of the ESCs derived cardiomyocytes, the chronotropic
effects of cardioactive drugs including isoprenaline, phenyleprine and carbacol were assessed
at three developmental stages, an early stage an intermediary stage and a terminal stage.
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Spontaneously beating EBs representing more than 10% of the outgrowths were
investigated at three distinct developmental stages: an early differentiation phase (shortly after
initiation of contractions (7+3d), an intermediate phase (day 7+7d) and terminal
differentiation phase (7+14d) as previously described by  Maltsev et al., 1994 (8). The
spontaneous beating frequency was measured by counting the pulsation rate of CMs
incubated in DMEM at 37°C on a heating plate of a phase-contrast inverted microscope.
The contracting EBs was fixed using 4% paraformaldehyde for immunostaining.
Antibodies used in this study included: citokeratin 1:50, titin as a cell-specific antigen for
cardiac and skeletal muscle, (7) betaIIItubulin for the neuronal differentiation (2), Oct-4 for
the presence of the undifferentiated ES cells.
The immunostaining was performed according to the recommended manufacturers’
instructions. Following the elimination of unbound secondary Abs by 3x PBS washings, the
EBs were Hoechst stained for 10 min at RT, 3x PBS washed and then we washed with double
distilled water. Cover slips with immunostained EBs were recovered and placed on
Vectashield Mounting Medium on chemically clean microscopic slides and examined with a
fluorescence microscope.
RESULTS AND DISCUSSIONS
In order to evaluate murine embryonic stem cell plasticity CDE1 cell line was
subjected to cardiac and neural differentiation using hanging drops and suspension method.
From the 7th day of plating (day 2+7) we could observed contractions in a synchronous
rhythm (table 1) (graphic 1). Best contracting cells, showing titin expression (fig.1), were
observed within the EBs grown in IMDM medium derived form the hanging-drop variant,
compared to EBs from suspension culture.The EBs obtained from suspension method were
smaller and the pulsing was retarded and uneven compared to the hanging-drop variant. In
cultures treated with retinoic acid the overall contractions of EBs were present, but at a lower
frequency than in the IMDM medium without RA, while contractions within EBs from
suspension culture were only rare noticed.
Table 1.









2+7 47,82 25 0 0
2+8 78,26 50 47,82 0
2+9 91,3 62,5 65,21 0
2+10 91,3 62,5 65,21 0
2+11 95,65 83,33 91,3 17,39
2+12 95,64 83,33 91,3 17,39
2+13 95,65 87,33 91,3 17,39
2+14 95,65 87,5 91,3 17,39
2+15 86,95 76,19 91,3 17,39
Was clearly seen under the RA treatment and best results were obtained from the EBs
produced in suspension. The neuronal inductive influence of RA treated EBs was earlier
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reported by Stübing (13). Committed neuronal lineage were observed in EBs from the
suspension variant 12 days after plating (Day2+12). Specific morphology of neuronal cells
and the networks of  synaptically coupled cells are clearly seen by immunocytochemical
detection of  betaIIItubulin (fig.1) and cytokeratin Endo-A (fig.1). However, within EBs there
were  present several undifferentiated, pluripotent cells expressing the Oct-4 marker.
Graphic 1. Percentage of pulsin clumbs in four different culture condition.
An in vitro culture system for the generation of functional cardiomyocytes from ESCs has
several potential applications, e.g. in the fields of developmental biology, transplantation
medicine, experimental pharmacology and teratology. Here we describe structural and
functional characteristics of cardiomyocytes derived from mouse embryonic stem cells. Our
data demonstrate that mouse embryonic stem cells can effectively differentiate into functional
cardiomyocytes during in vitro development. This conclusion is based on: (1) the contractility
of the differentiated cells, (2) the specific expression of multiple cardiac-associated molecular
markers by the differentiated cells, (3) the appropriate response of these cells to cardioactive
drugs.
Assessments of neuronal differentiation have been performed by adding in the culture
medium of retinoic acid four times. Following these maneuvers were found in culture
appearance of fine nerve filaments positive for the marker used for immunohistochemistry.
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Figure 1 - Titin (A), Beta3tubulin (B), and citokeratin (C) expression in attached EB on gelatin coated surface
Was clearly seen under the RA treatment and best results were obtained from the EBs
produced in suspension. The neuronal inductive influence of RA treated EBs was earlier
reported by Stübing (13). Committed neuronal lineage were observed in EBs from the
suspension variant 12 days after plating (day2+12). Specific morphology of neuronal cells
and the networks of  synaptically coupled cells are clearly seen by immunocytochemical
detection of  betaIIItubulin (Fig.1) and cytokeratin Endo-A (Fig.1). However, within EBs
there were  present several undifferentiated, pluripotent cells expressing the Oct-4 marker.
Contracting clusters showed positive or negative chronotropic responses to all
administrated drugs, from the early stage (day 7 + 3) of differentiation.
The increase in beating frequency by β1-adrenoceptor agonist, Isoprenalyne was alike
in both control and experimental groups. The rate of beating was, subsequently, monitored.
Significant positive chronotropic effects on the cardiomyocytes were observed after the
application of isoprenaline from an early stage. However, the response to this drug was
similar at the late stage. Phenylephrine enhanced the rate of beating frequency at all the
developmental stages.




 it was thus found that the addition of retinoic acid in culture medium leads to inhibition of
initial differentiation on cardiac lineage and promote the development of neural cells in
parallel (filaments);
 the embryoid bodies obtained after aggregation in suspension treated with retinoic acid
was found the occurrence of elongated cells, which formed thin bridges linking some
groups of contractile cells;
 by analisys of EBs derived from HD method and treated with RA was not observed such
filaments, however, found the sharp decrease in the number of cells with spontaneous
contractions;
 in conclusion, hanging-drop method provides a practical way of generating single EBs
from a defined number of cell;
 EBs from the suspension culture method were smaller and unequal in size, compared to
the hanging-drop procedure. Cardiomyocytes begun to contract spontaneously seven days
after plating of EBs (day2+7). They were localised between an epithelial and a basal
mesenchimal layer. The hanging-drop method showed better results on the field of cardiac
differentiation. The beating cardiac muscle clumps showed more synchronous rhythm
than those seen in EBs obtained from suspension culture method, where the b eating
cardiac muscle clumps pulsing cells appeared later, had a lower frequency and were
uneven;
 when RA was added to the culture medium, we could observed contracting clumps in EBs
obtained by the hanging-drop method later then without RA tratment (day2+8), while in
EBs obtained by suspension method contractions appeared later (day2+11) and less
frequently. Addition of RA induced committed neuronal lineage seen in EBs from the
suspension variant 12 days after plating (day2+12). The synaptic networks of neuronal
cells were best developed in EBs from suspension, compared to those observed in EBs
from hanging-drop method. Immunocytochemical detection of specific cellular antigens
proved the specificity of EBs commitment towards cardiomyocytes and neuronal lineages;
 Our results demonstrated that CDE1 stem cells line could effectively differentiate into
functional cardiomyocytes. This conclusion is based on the contractility of the
differentiated cultures, appropriate response of these differentiated cells to cardioactive
drugs, specific expression of multiple cardiac associated and molecular markers by the
differentiated cells.
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